Multiple system atrophy (MSA)
Multiple system atrophy (MSA) is a fatal, adult-onset, neurodegenerative disease with rapid progression and limited symptomatic treatment options
- clinical features include parkinsonism and cerebellar and autonomic signs and symptoms in various combinations
- two major motor variants are distinguished according to the predominant motor presentation:
- MSA parkinsonian variant (MSA-P) and
- MSA cerebellar variant (MSA-C)
- two major motor variants are distinguished according to the predominant motor presentation:
- in Europe and North America, the distribution is in favor of the MSA-P variant, whereas MSA-C is more prevalent in Japan.
- neuropathological correlates of MSA-P and MSA-C are striatonigral degeneration and olivopontocerebellar atrophy, respectively
Shy-Drager syndrome is considered another form of MSA.
Pathologically multiple system atrophy is characterised by widespread neuronal loss and gliosis.
Clinically there are three distinct pictures according to which parts of the brain are most severely affected:
- cerebellar ataxia in OPCA (MSA-C)
- Parkinsonism in strionigral degeneration (MSA-P)
- autonomic failure in Shy-Drager syndrome
Reference:
- Poewe W et al. Multiple system atrophy. Nat Rev Dis Primers. 2022 Aug 25;8(1):56.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.